US Patent Issued to Beijing Innocare Pharma Tech on May 13 for "Crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamide" (Chinese Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,188, issued on May 13, was assigned to Beijing Innocare Pharma Tech Co. Ltd. (Beijing).

"Crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamide" was invented by Xiangyang Chen (Beijing) and Jing Feng (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to various crystalline forms of (S)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1H-pyrazole-4-carboxamide. The present invention also relates to pharmaceutical compositions comprising the crystalline forms."

The patent was filed on June 14, 2022, under Applica...